Avelar Rui's Form 4 filing
Evolus, Inc. (EOLS) · filed Aug 16, 2023
- Accession no.
- 0001570562-23-000100
- Filed
- Aug 16, 2023
- Trade date
- Aug 14-16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $22.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Avelar RuiCIK 0001432063 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | Common Stock | AGrant or awardAcquired | +19,672 | $0.00 | $0 | 355,597 | Direct | |
| Aug 16, 2023 | Common Stock | SSaleDisposed | −2,211 | $10.27 | −$22,706.97 | 353,386 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Chief Medical Officer and Head of Research & Development